Proven, integrated iPSC-platform to support multi-year drug discovery programs.
For more than a decade, Ncardia has partnered with biotech and pharmaceutical organizations to tackle one of the biggest challenges in drug discovery: 9 out of 10 drugs fail the first time they contact a human.
Regardless of your modality, you can dramatically improve those odds by using an integrated iPSC-based drug discovery platform that allows you to mimic drug interactions with the human body from hit identification to lead optimization.
What are you looking for?
- Custom iPSC generation, differentiation and supply
- Readily available iPSC-models
- Assay development
- Established disease in vitro models and assays amenable for high-throughput screening
- Custom projects based on iPSC technology
Site |
Badges |
|
Ncardia Services BV
BioPartner 1. J.H. Oortweg 21
Leiden, , 2333 CH
Netherlands
|
|
|
Ncardia Services B.V.
BioPartner 1. J.H. Oortweg 21
Leiden, , 2333 CH
Netherlands
|
|